Watson & Company, a digital healthcare company, participated in 'KIMES 2021' held in BEXCO, Busan from October 29 to 31, Introducing 'POCUS'. It has a good reputation among public institutions and consumers due to sleep disorders, concentration, and depression.
POCUS is the first mental wearable health care device for consumers and public institutions launched in Korea. Transcranial Direct Current Stimulation (tDCS) technology that accelerates brain activation is applied. It works as a mechanism to improve the thinking ability, by lowering the intensity of current compared to devices used in medical institutions and sending a safe and minute current (1mA) to the frontal lobe of the consumer's brain to balance the left and right brains.
The effectiveness of the product was proven through various pilot projects with the Fire Department, public health center, and female professional golf players in the first half of 2021. As a public institution, in a pilot project targeting 40 firefighters in Daejeon, the improvement effect was confirmed in the areas of stress, sleep improvement, and depression. In addition, the number of strokes, putting, and recovery improved in the domestic KLPGA professional golf player pilot project, which improved performance compared to the previous year. In addition, the effect of improving the concentration of the players was also verified.
And Watson & Company, through exploratory clinical trials with Incheon St. Mary's Hospital, confirmed the research results that the tDCS stimulator 'POCUS' increases local cerebral blood flow in the frontal and temporal lobes. In the neuropsychological test, the results of the backward digit span, KBNT (Korean version of the Boston name waiting test), and the Stroop test, which are partial variables of working memory, improved, the company said.
Increased local cerebral blood flow in both frontal and temporal lobes after 4 weeks of tdcs stimulation
(uncorrected P < 0.01)
Research results showing that local cerebral blood flow in the prefrontal and temporal lobes increased after the use POCUS(Photo by Watson & Company)
Professor Yong-an Jung, head of the Brain Science Intermediation Research Center at Incheon St. Mary's Hospital, who led this study, said, "The results of the study showed that cerebral blood flow to the prefrontal and temporal lobes increased even through the use of focus, and through this, effects such as improvement of depression and improvement of concentration can be expected, and working memory part could be improved directly.”
Watson & Company said, "Based on the results of this study, we plan to proceed with the approval of medical devices in 2022. To be reborn as a global digital treatment company, we plan to expand our business globally through electronic insomnia medicine, electronic hair loss medicine, and mental data subscription service,” the company said.